Marketing diagnostic shotgun metagenomics to patients and clinicians this way is surely the height of irresponsibility. https://twitter.com/Aperiomics/status/1092558424544444421 …
Deze Tweet is niet beschikbaar.
-
I second Nick's comments - this is a bunch of hooey and as far as I can tell, no publications or clinical trials (from your company) to back up your claims. Remember Theranos? Metagenomic diagnostics are simple in principle, but incredibly difficult in reality - trials needed!
I specifically object to this part 
.
Very curious to see some evidence for that claim...pic.twitter.com/03M30HdZ8f
